Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment

Kouanfack, C.; Montavon, C.; Laurent, C.; Aghokeng, A.; Kenfack, A.; Bourgeois, A.; Koulla-Shiro, S.; Mpoudi-Ngole, E.; Peeters, M.; Delaporte, E.; Kouanfack, C; Montavon, C; Laurent, C; Aghokeng, A; Kenfack, A; Bourgeois, A; Koulla-Shiro, S; Mpoudi-Ngole, E; Peeters, M; Delaporte, E

doi:10.1086/597779

Home

>

Node

>

Subnode

Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment

Kouanfack, C.; Montavon, C.; Laurent, C.; Aghokeng, A.; Kenfack, A.; Bourgeois, A.; Koulla-Shiro, S.; Mpoudi-Ngole, E.; Peeters, M.; Delaporte, E.

Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America 48(9): 1318-1322

2009

ISSN/ISBN: 1537-6591

PMID: 19320592

DOI: 10.1086/597779

Document Number: 205498

A cross-sectional study, performed at a routine human immunodeficiency virus (HIV)/AIDS clinic in Cameroon that uses the World Health Organization public health approach, showed low rates of virological failure and drug resistance at 12 and 24 months after initiation of antiretroviral therapy. Importantly, the cross-sectional study also showed that the World Health Organization recommendation for second-line treatment would be effective in almost all patients with HIV drug resistance mutations.